Polytetrafluoroethylene Graft Survival in Hemodialysis

JAMA: The Journal of the American Medical Association

Volumn 249, Issue 2, 1983, Pages 219-222

  Munda, Rino ^a   First, M Roy ^a   Alexander, J Wesley ^a   Linnemann, Calvin C ^a   Fidler, James P ^a   Kittur, Dilip ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS FLUID; HEPARIN; IMPRA; KANAMYCIN; MEPIVACAINE; POLITEF; UNCLASSIFIED DRUG;

ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; ARTERY INTIMA PROLIFERATION; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD VESSEL PROSTHESIS; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL STUDY; HEMODIALYSIS; HUMAN; INFECTION; PERIPHERAL VASCULAR SYSTEM; POLITEF IMPLANT; THERAPY; THROMBOSIS;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; RENAL DIALYSIS; THROMBOSIS; TIME FACTORS;

EID: 84944659298     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1983.03330260037028     Document Type: Article

References (20)

1. Lefrak EA, Noon GP: Surgical technique for creation of an arteriovenous fistula using a looped bovine graft. Ann Surg 1975;182:782-785.
2. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;8:699-712.
3. Kempczinski RF: Physical characteristics of implanted polytetrafluoroethylene grafts. Arch Surg 1979;144:917-919.
4. Brescia MJ, Cimino JE, Appel K, et al.: Chronic hemodialysis using created arteriovenous fistula. N Engl J Med 1966;275:1089-1092.
5. Crockett RE: Blood access for haemodialysis. Nephron 1974;12:338-354.
6. Morgan AP, Dammin GJ, Lazarus JM: Failure modes in secondary vascular access for hemodialysis. J Am Soc Artificial Organs 1978; 1:44-52.
7. Mohaideen AH, Mendivil J, Avram MM, et al.: Arteriovenous access utilizing modified bovine arterial grafts for hemodialysis. Ann Surg 1977;186:643-650.
8. Lindenauer SM, Williams R: Dacron[unk] velour arteriovenous fistula for hemodialysis access. Ann Surg 1981;193:43-48.
9. Tellis VA, Kohlberg WI, Bhat DJ, et al.: Expanded polytetrafluoroethylene graft fistula for chronic hemodialysis. Ann Surg 1979;189:101-105.
10. Jenkins AMcL, Buist TAS, Glover SD: Medium-term follow-up of forty autogenous vein and forty polytetrafluoroethylene (Gore-Tex) grafts for vascular access. Surgery 1980;88:667-672.
11. Carrel A, Guthrie CC: Results of the biterminal transplantation of veins. Am J Med Sci 1906;132:415-422.
12. Walden R, L'Italien GH, Megerman J, et al.: Matched elastic properties and successful arterial grafting. Arch Surg 1980;115:1166-1169.
13. Imparato AM, Bracco A, Kim GE, et al.: Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions. Surgery 1972;72:1007-1017.
14. Oblath RW, Bucklet FO Jr, Green RM, et al.: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 1978;84:37-44.
15. Bone GE, Pomjzl MJ: Management of dialysis fistula thrombosis. Am J Surg 1979; 138:901-906.
16. McCann RL, Hager PO, Fuchs JC: Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts. Ann Surg 1980; 191:238-243.
17. Roon AJ, Malone JM, Moore WS, et al.: Bacteremic infectability: A function of vascular graft material and design. J Surg Res 1977; 22:489-498.
18. Dobbelstein H: Immune system in uremia. Nephron 1976;17:409-414.
19. Bhat DJ, Tellis VA, Kohlberg WI, et al.: Management of sepsis involving expanded polytetrafluoroethylene grafts for hemodialysis access. Surgery 1980;87:445-450.
20. Butt KMH, Ortega-Gaylan M, Shirani K, et al.: Angioaccess in uremic diabetics, in Friedman EA, L'Esperance FA Jr (eds): Diabetic-Renal Retinal Syndrome. New York, Grune & Stratton Inc, 1980.